HomeInsightsPB

Glaxosmithkline Consumer Healthcare Ltd(merged) PB Ratio

Glaxosmithkline Consumer Healthcare Ltd(merged) PB Ratio

stocks purchased

₹ 2.7 Cr

Volume transacted

stocks purchased

2.5 K

stocks traded

Last Updated time: 19 Sep 15:30 PM

From Blinkx's GPT

No data available

Key Highlights

No data available

Share price Over Time

1M

1Y

3Y

5Y

Monitoring GlaxoSmithkline Consumer Healthcare Ltd(Merged) share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
15 Apr 202010753.65
13 Apr 202010232.35
09 Apr 202010365.65
08 Apr 202010615.25
07 Apr 202010590.7
03 Apr 20209367.15
01 Apr 20209548.3
31 Mar 20209993.1
30 Mar 20209452.1
27 Mar 20209413.55

SWOT Analysis Of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for GlaxoSmithkline Consumer Healthcare Ltd(Merged)

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

Market Value

0

Asset Value

0

* All values are in Rupees

Key Valuation Metric of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

Historical Market Cap of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

Historical Revenue of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

Historical EBITDA of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

Historical Net Profit of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

Dividend per Share (DPS) Over Time

No data available

GlaxoSmithkline Consumer Healthcare Ltd(Merged) News Hub

News

Board of GlaxoSmithkline Consumer Healthcare takes on record sanction of scheme of merger

The Board of GlaxoSmithkline Consumer Healthcare at its meeting held on 01 April 2020 has ...

Read more

01 Apr 202012:47

News

GlaxoSmithkline Consumer Healthcare to convene board meeting

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

17 Mar 202010:43

News

GlaxoSmithkline Consumer Healthcare to convene board meeting

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

13 Jan 202016:32

News

GlaxoSmithkline Consumer Healthcare to announce Quarterly Result

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

15 Oct 201910:38

News

GlaxoSmithkline Consumer Healthcare Ltd up for third straight session

GlaxoSmithkline Consumer Healthcare Ltd is up for a third straight session today. The stoc...

Read more

17 Sep 201913:05

News

GlaxoSmithkline Consumer Healthcare Ltd gains for third straight session

GlaxoSmithkline Consumer Healthcare Ltd gained for a third straight session today. The sto...

Read more

22 Aug 201913:05

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PB Ratio of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

What is the PB ratio of GlaxoSmithkline Consumer Healthcare Ltd(Merged)?

The current PB ratio of GlaxoSmithkline Consumer Healthcare Ltd(Merged) is 0.0. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy GlaxoSmithkline Consumer Healthcare Ltd(Merged) stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for GlaxoSmithkline Consumer Healthcare Ltd(Merged). Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of GlaxoSmithkline Consumer Healthcare Ltd(Merged) calculated?

The PB ratio of GlaxoSmithkline Consumer Healthcare Ltd(Merged) is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for GlaxoSmithkline Consumer Healthcare Ltd(Merged)?

A high PB ratio suggests that GlaxoSmithkline Consumer Healthcare Ltd(Merged)’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for GlaxoSmithkline Consumer Healthcare Ltd(Merged)?

A low PB ratio of GlaxoSmithkline Consumer Healthcare Ltd(Merged) may indicate that the stock is undervalued or it is facing financial difficulties.

Can GlaxoSmithkline Consumer Healthcare Ltd(Merged) PB Ratio change over time?

Yes, the PB ratio of GlaxoSmithkline Consumer Healthcare Ltd(Merged) can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*